Quick Facts at a Glance
- Recall Date
- November 18, 2025
- Hazard Level
- HIGH
- Brands
- NEBIVOLOL, AvKARE
- Category
- Health & Personal Care
- Sold At
- Multiple Retailers
- Geographic Scope
- 1 states
- At-Risk Groups
- GENERAL
What to Do Now
Use this page like a recall checklist: verify the product first, then act on the official remedy.
Immediate steps
- 1Stop using the product until you confirm whether it is included in the recall.
- 2Compare the product label, model number, UPC, color, size, and purchase location against the identifiers below.
- 3Follow the official remedy from FDA - Drug Safety; save photos, receipts, labels, and correspondence before contacting the company.
- 4If the product could harm a child, older adult, pet, or patient, move it out of reach immediately.
Check these identifiers
- Brand
- NEBIVOLOL, AvKARE
- Product type
- Nebivolol Tablets
- Model numbers
- Lot# 17240988, Exp. 05/31/2026
- UPC codes
- 42291-871, 42291-872, 42291-873, 42291-874, 42291-871-30, 42291-872-90, 42291-873-90, 42291-874-90
- Sold at
- Multiple Retailers
- Where affected
- ALL
Recall Timeline
Key dates and source checks for this recall record.
Recall announced
November 18, 2025
Reported by FDA DRUG
December 17, 2025
RecallRadar source check
December 24, 2025
Consumer action
Use the official remedy and keep documentation.
Hazard Information
Cross Contamination with Other Products
What You Should Do
Consumers and healthcare providers should stop using this product immediately. Contact Glenmark Pharmaceuticals Inc., USA or your healthcare provider for guidance. Notification method: Letter
About This Product
Nebivolol is a medication used to treat high blood pressure and heart conditions. It is typically prescribed for hypertension management and can help lower the risk of heart-related issues.
Why This Is Dangerous
The recall was initiated due to cross-contamination with other products, which can compromise the safety and effectiveness of the medication.
Industry Context
This recall is not part of a broader industry pattern.
Real-World Impact
Consumers should stop using the product to avoid potential health risks. This recall may cause inconvenience for those relying on the medication.
Practical Guidance
How to identify if yours is affected
- Check the lot number on the bottle.
- Verify the expiration date is May 31, 2026.
- Confirm the product was purchased from a retailer in the U.S.
Where to find product info
Lot numbers and expiration dates are typically printed on the medicine bottle label.
What timeline to expect
Refund processing can take approximately 4-6 weeks after returning the product.
If the manufacturer is unresponsive
- Follow up with Glenmark Pharmaceuticals via phone or email.
- Document all communication and keep records of your return.
How to prevent similar issues
- Always check for recalls before using medications.
- Consult with your healthcare provider about any concerns regarding your prescriptions.
- Be aware of signs of contamination, such as unusual side effects.
Documentation advice
Keep receipts, correspondence regarding the recall, and any evidence of the product for your records.
Get instant alerts for Health & Personal Care recalls
Be the first to know. Free instant alerts to your inbox.
Product Details
The recall involves Nebivolol Tablets, 20 mg, sold in 90-count bottles. The products were manufactured by Glenmark Pharmaceuticals Limited in India for Avkare, Pulaski, TN. The affected lot number is 17240988, with an expiration date of May 31, 2026.
Key Facts
- Manufactured for Avkare
Browse More Recalls
Safety Guide
Not sure what to do next? Our guide walks you through the process step by step.
Read: What to Do When You Find a Recalled ProductGet Alerts for Health & Personal Care Recalls
Get instant alerts for recalls that affect you. Free forever.
